The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
A Functional Role of HLA-G Expression in Human Gliomas: An Alternative Strategy of Immune Escape
Open accessAbstract
HLA-G is a nonclassical MHC molecule with highly limited tissue distribution that has been attributed chiefly immune regulatory functions. Glioblastoma is paradigmatic for the capability of human cancers to paralyze the immune system. To delineate the potential role of HLA-G in glioblastoma immunobiology, expression patterns and functional relevance of this MHC class Ib molecule were investigated in glioma cells and brain tissues. HLA-G mRNA expression was detected in six of 12 glioma cell lines in the absence of IFN-γ and in 10 of 12 cell lines in the presence of IFN-γ. HLA-G protein was detected in four of 12 cell lines in the absence of IFN-γ and in eight of 12 cell lines in the presence of IFN-γ. Immunohistochemical analysis of human brain tumors revealed expression of HLA-G in four of five tissue samples. Functional studies on the role of HLA-G in glioma cells were conducted with alloreactive PBMCs, NK cells, and T cell subpopulations. Expression of membrane-bound HLA-G1 and soluble HLA-G5 inhibited alloreactive and Ag-specific immune responses. Gene transfer of HLA-G1 or HLA-G5 into HLA-G-negative glioma cells (U87MG) rendered cells highly resistant to direct alloreactive lysis, inhibited the alloproliferative response, and prevented efficient priming of cytotoxic T cells. The inhibitory effects of HLA-G were directed against CD8 and CD4 T cells, but appeared to be NK cell independent. Interestingly, few HLA-G-positive cells within a population of HLA-G-negative tumor cells exerted significant immune inhibitory effects. We conclude that the aberrant expression of HLA-G may contribute to immune escape in human glioblastoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
A Class I Antigen, HLA-G, Expressed in Human Trophoblasts
Kovats, S., Main, E. K., Librach, C., Stubblebine, M., Fisher, S. J., & DeMars, R. (1990) · Science · doi:10.1126/science.2326636 · Cited by 1,407
Rouas-Freiss, N., Gonçalves, R. M.-B., Menier, C., Dausset, J., & Carosella, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11520 · Cited by 701
Fournel, S., Aguerre-Girr, M., Huc, X., Lenfant, F., Alam, A., Toubert, A., Bensussan, A., & Le Bouteiller, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6100 · Cited by 463
HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
Paul, P., Rouas-Freiss, N., Khalil-Daher, I., Moreau, P., Riteau, B., Le Gal, F. A., Avril, M. F., Dausset, J., Guillet, J. G., & Carosella, E. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4510 · Cited by 432
Englerblum, G., Meier, M., Frank, J., & Muller, G. A. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1189 · Cited by 407
Rouas-Freiss, N., Marchal, R. E., Kirszenbaum, M., Dausset, J., & Carosella, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5249 · Cited by 353
Weller, M., Frei, K., Groscurth, P., Krammer, P. H., Yonekawa, Y., & Fontana, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117462 · Cited by 345
Self-citationHLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes
Le Gal, F.-A., Riteau, B., Sedlik, C., Khalil-Daher, I., Menier, C., Dausset, J., Guillet, J.-G., Carosella, E. D., & Rouas-Freiss, N. (1999) · International Immunology · doi:10.1093/intimm/11.8.1351 · Cited by 316
Lila, N., Rouas-Freiss, N., Dausset, J., Carpentier, A., & Carosella, E. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201407398 · Cited by 314
Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes
Zavazava, N., & Krönke, M. (1996) · Nature Medicine · doi:10.1038/nm0996-1005 · Cited by 262
HLA-G suppresses proliferation of CD4+ T-lymphocytes
Bainbridge, D. R. J., Ellis, S. A., & Sargent, I. L. (2000) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(00)00070-x · Cited by 243
WELLER, M., & FONTANA, A. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00010-0 · Cited by 230
Self-citationNonclassical HLA-G molecules are classical peptide presenters
Diehl, M., Münz, C., Keilholz, W., Stevanović, S., Holmes, N., Loke, Y. W., & Rammensee, H.-G. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00481-5 · Cited by 200
HLA‐G has a concentration‐dependent effect on the generation of an allo‐CTL response
Kapasi, K., Albert, S. E., Yie, S. ‐., Zavazava, N., & Librach, C. L. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00109.x · Cited by 194
Loss of HLA haplotype and B locus down-regulation in melanoma cell lines.
Marincola, F. M., Shamamian, P., Alexander, R. B., Gnarra, J. R., Turetskaya, R. L., Nedospasov, S. A., Simonis, T. B., Taubenberger, J. K., Yannelli, J., Mixon, A., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.3.1225 · Cited by 165
Ibrahim, E. C., Guerra, N., Terrier-Lacombe, M.-J., Angevin, E., Chouaïb, S., Carosella, E. D., Caignard, A., & Paul, P. (2001) · PubMed · Cited by 157
HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition
Riteau, B., Menier, C., Khalil‐Daher, I., et al. (2001) · International Immunology · doi:10.1093/intimm/13.2.193 · Cited by 152
Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies.
Paul, P., Cabestré, F. A., Gal, F. L., Khalil, I., Danff, C. L., Schmid, M., Mercier, S., Avril, M.-F., Dausset, J. B., Guillet, J., et al. (1999) · PubMed · Cited by 144
HLA-G and HLA-E: fundamental and pathophysiological aspects
Carosella, E. D., Paul, P., Moreau, P., & Rouas‐Freiss, N. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01707-2 · Cited by 117
Wagner, S. N., Rebmann, V., Willers, C. P., Grosse‐Wilde, H., & Goos, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02486-7 · Cited by 103
The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein
Ulbrecht, M., Honka, T., Person, S., Johnson, J., & Weiss, E. H. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.9.2945 · Cited by 80
Self-citationCD95 Ligand: Lethal Weapon Against Malignant Glioma?
Weller, M., Kleihues, P., DICHGANS, J., & Ohgaki, H. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00154.x · Cited by 75
Self-citationFrumento, G., Franchello, S., Palmisano, G. L., Nicotra, M., Giacomini, P., Loke, Y. W., Geraghty, D. E., Maio, M., Manzo, C., Natali, P. G., et al. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.560104.x · Cited by 56
Expression and regulation of HLA-G in human glioma cell lines
Maier, S., Geraghty, D. E., & Weiss, E. H. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(99)00186-4 · Cited by 28
Self-citation
Cited by
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Current state of immunotherapy for glioblastoma
Lim, M., Xia, Y., Bettegowda, C., & Weller, M. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0003-5 · Cited by 1,365
Self-citationThree or more routes for leukocyte migration into the central nervous system
Ransohoff, R. M., Kivisäkk, P., & Kidd, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1130 · Cited by 1,052
Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
Mohme, M., Riethdorf, S., & Pantel, K. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.144 · Cited by 602
Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V. M., Allan, D. S. J., Makadzange, A., Rowland-Jones, S., Willcox, B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1431057100 · Cited by 557
Metadata
- Authors
- Wiendl, H., Mitsdoerffer, M., Hofmeister, V., Wischhusen, J., Bornemann, A., Meyermann, R., Weiss, E. H., Melms, A., & Weller, M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-05-01
- Volume
- 168
- Issue
- 9
- Pages
- 4772-4780
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1568276869
- Cited by
- 325
- References
- 25
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.